BRAF and melanoma: Although there is no direct nor mechanistic evidence of the MITF-CRYAB transcriptional axis in other cancer types, in melanoma both MITF and CRYAB expression are upregulated by BRAF/MEK-inhibitor treatments57,60, suggesting that this regulation can go beyond both PCa scenario.